Answers are grounded in this paper and cite their sources.
In 2012, of 1.5 million infants born to HIV-infected mothers globally, 250,000 acquired HIV, allowing estimation of the HIV-exposed uninfected (HEU) population.1 Many studies show higher rates of mortality and morbidity in HEU than HIV-unexposed (HU) children. For example, in the large Zimbabwe Vitamin A for Mothers and Babies Project (ZVITAMBO) conducted between 1997 and 2001, before combination antiretroviral therapy (cART) and trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis were available, mortality in HEU (8.1%) was almost 4-fold higher that in HU infants (2.2%).2 Increased incidence of lower respiratory tract infections and mucocutaneous candidiasis in HEU infants were observed.3 RISK FACTORS HIV in Pregnancy Maternal well-being influences infant health. Prematurity, low birth weight and small for gestation, all risk factors for infant mortality, are associated with maternal HIV infection. In a large retrospective study from Botswana, maternal HIV infection was associated with small for gestational age (odds ratio, 1.8: 1.7–1.9) and preterm delivery (odds ratio, 1.3: 1.3–1.4), after adjusting for maternal age, nulliparity, hypertension in pregnancy and anemia.4 In Zambia, Kuhn et al. showed that infants of mothers with CD4+ T cell counts <350 cells/mL were more likely to die (hazard ratio, 2.87; 95% confidence interval [CI], 1.03–8.03) or be hospitalized (hazard ratio, 2.28; 95% CI, 1.17–4.45) after adjusting for maternal death and low birth weight. In the ZVITAMBO study, a maternal CD4+ T cell count >800 cells/mm3 was found to be protective against infectious diseases morbidity.3 Maternal immunosuppression predisposes to congenital and perinatally acquired infections, which includes Mycobacterium tuberculosis, cytomegalovirus (CMV), syphilis, hepatitis B virus (HBV) and hepatitis C virus (HCV). Infant Feeding Breast-feeding is protective throughout the first 2 years of life, and especially in early infancy. As breast-feeding contributes to vertical transmission of HIV, replacement feeding using infant formula milks is recommended when accessible, feasible, affordable, sustainable and safe.5 However, in the areas where most HEU infants live, formula feeding is not a safe option. In a dramatic example highlighting the disadvantages of formula use in this setting, in a single hospital in Botswana during a diarrhea outbreak, 69 of 141 children requiring hospitalization for severe diarrhea were formula-fed HEU infants.6 Lack of Vaccine-induced Antibodies in the First Few Months of Life At birth and until the first immunizations are given, HEU infants were shown to have very low levels of antibodies (ie, below the threshold for protection) to pertussis, tetanus, pneumococcus and Haemophilus influenzae type B, partly explaining increased vulnerability to infectious diseases.7 In a second study from the same area (Cape Town), HEU infants also had low antibody levels to measles and HBV. However, HEU infants responded well to vaccines and for pertussis, responded better than HU infants.8 SPECIFIC DISEASES Tuberculosis Maternal tuberculosis can have grave consequences for infants. Pillay et al. described vertical M. tuberculosis transmission in 11 (14%) of 82 mothers coinfected with HIV and TB. Prematurity and intrauterine growth retardation occurred commonly.9 In a report from Cape Town, 27 of 41 infants whose mothers had TB and 6 of 8 infants with congenital TB were HEU. Median gestational age of TB-exposed infants was 36 (interquartile range, 33–38) weeks, and birth weight was 1.950 kg (interquartile range, 1.537–2.283 kg). The majority of mothers were only investigated once TB was clinically suspected.10 In a double-blinded randomized trial comparing preexposure isoniazid versus placebo in HIV-infected and HEU infants in Southern Africa between 2004 and 2008, isoniazid had no effect on TB incidence. Infants were enrolled between 3 and 4 months of age. In HEU children, the incidence of pulmonary TB was 4100 per 100,000 child years, a third of that in HIV-infected children.11 Comparing TB incidence in HEU infants with that from a Bacille Calmette-Guérin trial in South Africa between 2001 and 2004 where the rate in children below 2 years of age was 866 per 100,0000 child years,12 HEU infants appear to have a 4-fold higher risk of TB disease. Pneumocystis jirovecii Pneumonia Pneumocystis jirovecii, a well-recognized cause of severe pneumonia in HIV-infected infants, peaks between 3 and 6 months of age if no intervention occurs. P. jirovecii pneumonia (PCP) was recognized in HEU infants in 1997, when a report described 2 infants in Houston, TX, presenting with PCP at around 50 days of age.13 Since then PCP has been identified in small numbers of HEU infants in South Africa.14 Cytomegalovirus Congenital CMV is a leading cause of hearing loss in children. In a recent study from Cape Town, 22 (2.9%) of 748 HEU infants had congenital CMV infection. Maternal CD4 count <200 cells/mm3 was the major risk factor for congenital CMV infection in multivariate analysis. Antenatal cART, present in 50% of the cohort, was found not to be protective.15 CMV colitis, necessitating bowel resection, has been described in an HEU infant aged 7 months with chronic diarrhea. Malnutrition may have contributed to severe CMV infection.14 Syphilis, Herpes Simplex-2 Virus, HBV and HBC These infections can be sexually transmitted. Unsuspected syphilis and herpes simplex-2 virus (HSV-2) infection either at labor or in the postpartum period was demonstrated in stored specimens from mothers in the ZVITAMBO study.16 Using a similar approach in Malawi, 119 (5.9%) of 2048 mothers of HEU infants had active HBV infection with 5 infants acquiring HBV by week 48.17 In New York City, 6 (12.8%) of 47 HEU infants whose mothers had HCV acquired HCV vertically in a retrospective study.18 CHANGING CIRCUMSTANCES—INCREASED USE OF CART FOR PREVENTION OF MOTHER TO CHILD TRANSMISSION IN AFRICA With more pregnant women accessing cART earlier and with higher CD4 counts and also integration of TB and HIV services, maternal health in HIV-infected women should continue to improve, likely with secondary benefits for HEU infants. However, increased exposure to antiretrovirals may have risks. For example, in Botswana, compared with zidovudine alone, nevirapine-based cART resulted in higher odds for preterm delivery (adjusted odds ratio, 1.4; 95% CI, 1.2–1.8) and small for gestational age (adjusted odds ratio, 1.5; 95% CI, 1.2–1.9).4 APPROACH HEU children require regular follow-up. The following should be addressed: For infant feeding, replacement feeding should be assessed according to accessible, feasible, affordable, sustainable and safe criteria. In most high HIV prevalence settings, exclusive breast-feeding for 6 months followed by gradual weaning, with protection through antiretrovirals, is essential. Maternal screening should take place for syphilis, HSV-2, HBV and HCV. Regional prevalence should guide decisions for HBV and HCV testing. Congenital CMV infection, with its risk for sensorineural hearing loss, requires screening in the first 3 weeks of life. PCP occasionally occurs in young HEU infants. Current World Health Organization guidelines recommend discontinuing TMP-SMX prophylaxis after exclusion of HIV infection in non–breast-feeding infants. Where formula feeding is the norm, TMP-SMX should continue until the HIV polymerase chain reaction test at 4 months of age is negative. In high HIV prevalence settings, prophylaxis should continue until the infant is fully weaned and HIV infection is excluded. TMP-SMX should continue to be given to HEU infants in malaria endemic areas.19 Currently, data from a randomized trial in rural Uganda show moderate efficacy until 2 years of age.20 In areas with high TB prevalence, mothers should be actively screened for TB, and if found to have active TB, their infants should be investigated. In the absence of disease in the infant, postexposure prophylaxis according to country guidelines is appropriate. Lastly, HEU infants and children remain at risk for acquiring HIV. Breast-feeding, particularly if the mother is nonadherent regarding either her own cART or giving the infant prophylactic nevirapine, is a risk. Also, premastication of food by a HIV-infected carer for a weaning infant has been implicated in HIV transmission and should be avoided, when feeding HEU infants.21 AREAS FOR RESEARCH Many aspects require more data. The potential impact of sexually transmitted infections such as HSV-2, syphilis, HBV and HCV on HEU infants requires further exploration. TB in high prevalence settings is still under-appreciated. The role of TMP-SMX in preventing PCP and malaria and its optimal duration in HEU infants require further investigation, as does potential poorer outcomes in pregnancy linked to cART. Duration of response to immunization requires longer-term follow-up. Lastly, biological mechanisms resulting in increased vulnerability of HEU infants to infection require further exploration.
No takes yet. Share an insight, caveat, or question.
Cotton et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: